slides · global inventory
List
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,539
Current window 90,601-90,630
Pages 3,685
Rows per page 30
Component
90,601-90,630 of 110,539
35
The slide uses a grouped bar chart to demonstrate the value-add of internal development stages.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
36
The donut charts illustrate the concept of a diversified portfolio, while the text box details the specific characteristics of the two partnership models.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
37
Absci | Investor Presentation Deck | 111 slidesAbsci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
38
The flywheel diagram illustrates the core operational cycle.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
40
Absci | Investor Presentation Deck | 111 slidesAbsci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
41
The slide uses a bracket to highlight which members of the leadership team are speaking today.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
48
The slide uses a timeline-like list to show career progression, followed by a visual showcase of current projects.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
50
The slide uses a simple block diagram to represent the core mechanism of an LLM.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
51
The slide uses a simple input-process-output flow to explain the core function of an LLM.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
53
The slide uses a simple input-process-output flow to demystify LLM architecture.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
59
Uses a central block to represent the Transformer architecture as a black-box processor.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
60
The slide uses a simple input-process-output flow to demystify LLM inference.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
70
Includes a diagram illustrating the progression from specific task models to general foundation models.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
75
Absci | Investor Presentation Deck | 111 slidesAbsci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
76
Absci | Investor Presentation Deck | 111 slidesAbsci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
83
The slide uses a Gantt-style chart to illustrate the overlap of two batches of targets.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
85
The slide features a circular flywheel diagram on the left and a breakdown of the wet lab validation process on the right.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
87
The slide uses a two-step process flow (1 and 2) to explain the technical methodology of their AI-driven drug discovery platform.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
94
Absci | Investor Presentation Deck | 111 slidesAbsci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
95
Absci | Investor Presentation Deck | 111 slidesAbsci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
98
The scatter plot shows a Pearson R of 0.74 for N=5389 data points.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
100
The slide uses a side-by-side comparison structure to detail the value proposition of two specific drug candidates.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
102
Includes a Kaplan-Meier survival curve and a biological diagram of TLS.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
108
The chart uses a horizontal bar format to represent development progress against a timeline of stages (Target Eval to IND).Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
04
The slide uses a structured comparison layout to differentiate between individual programs and a combination strategy.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Spyre Therapeutics
Pitch deck Investor relations 1 hit
12
Aeglea BioTherapeutics | Investor Presentation Deck | 37 slidesAeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Spyre Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
37
Includes a footnote regarding a 1-for-25 reverse stock split effective September 8, 2023.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Spyre Therapeutics
Pitch deck Investor relations 1 hit
05
The chart is a scatter plot showing maintenance remission rates vs. dosing frequency, positioning current therapies in a cluster and the company's target in a superior quadrant.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Spyre Therapeutics
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
13
Aeglea BioTherapeutics | Investor Presentation Deck | 38 slidesAeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Spyre Therapeutics
Pitch deck Investor relations 1 hit
38
Includes a footnote regarding a 1-for-25 reverse stock split effective September 8, 2023.Aeglea BioTherapeutics | Investor Presentation Deck | 38 slides · Spyre Therapeutics
Pitch deck Investor relations 1 hit